Journal article · 2025 · Open access

Artificial intelligence in drug discovery and development: transforming challenges into opportunities

Shashi Kant, Deepika, Saheli Roy

Discover Pharmaceutical Sciences, 1(1) · Published 2 June 2025 · DOI 10.1007/s44395-025-00007-3

Free PDFView at the publisherCite this paper

In brief

“Artificial intelligence in drug discovery and development: transforming challenges into opportunities” is a 2025 journal article by Shashi Kant and 2 co-authors, published in Discover Pharmaceutical Sciences. OpenAlex counts 89 citations as of 15 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Discover Pharmaceutical Sciences.

Citations
89
Most cited in
2026 (67)
Field-weighted impact
25.13
References
113
Authors
3

Abstract

Artificial intelligence (AI) has revolutionized drug discovery and development by accelerating timelines, reducing costs, and increasing success rates. AI leverages machine learning (ML), deep learning (DL), and natural language processing (NLP) to analyze vast datasets, enabling the rapid identification of drug targets, prediction of compound efficacy, and optimization of drug design. It accelerates lead discovery by predicting pharmacokinetics, toxicity, and potential side effects while also refining clinical trial designs through improved patient recruitment and data analysis. This review highlights the diverse benefits of AI in drug development, including enhanced efficiency, greater accuracy, and minimized risks. It also discussess critical challenges, such as data quality, model interpretability, and regulatory hurdles. Future advancements in AI-powered drug discovery will require a focus on improving data standardization, fostering transparency in AI model development, and strengthening collaboration between AI researchers and pharmaceutical experts. By addressing these challenges, AI holds the potential to transform the healthcare landscape by delivering safer, more effective, and more affordable medicines to patients.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Kant, S., Deepika, & Roy, S. (2025). Artificial intelligence in drug discovery and development: transforming challenges into opportunities. Discover Pharmaceutical Sciences, 1(1). https://doi.org/10.1007/s44395-025-00007-3

MLA 9

Kant, Shashi, et al. “Artificial intelligence in drug discovery and development: transforming challenges into opportunities.” Discover Pharmaceutical Sciences, vol. 1, no. 1, 2025. https://doi.org/10.1007/s44395-025-00007-3.

Chicago

Kant, Shashi, Deepika, and Saheli Roy. 2025. “Artificial intelligence in drug discovery and development: transforming challenges into opportunities.” Discover Pharmaceutical Sciences 1 (1). https://doi.org/10.1007/s44395-025-00007-3.

Harvard

Kant, S., Deepika and Roy, S. (2025) ‘Artificial intelligence in drug discovery and development: transforming challenges into opportunities’, Discover Pharmaceutical Sciences, 1(1). doi:10.1007/s44395-025-00007-3.

IEEE

S. Kant, Deepika, and S. Roy, “Artificial intelligence in drug discovery and development: transforming challenges into opportunities,” Discover Pharmaceutical Sciences, vol. 1, no. 1, 2025, doi: 10.1007/s44395-025-00007-3.

BibTeX

@article{kant2025artificial,
  title     = {{Artificial intelligence in drug discovery and development: transforming challenges into opportunities}},
  author    = {Kant, Shashi and Deepika and Roy, Saheli},
  journal   = {Discover Pharmaceutical Sciences},
  year      = {2025},
  volume    = {1},
  number    = {1},
  doi       = {10.1007/s44395-025-00007-3},
  url       = {https://doi.org/10.1007/s44395-025-00007-3}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202411
20252121
20266767

Its field-weighted citation impact is 25.13: it has been cited 25.13 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence in drug discovery
  • drug development
  • machine learning
  • deep learning
  • natural language processing
  • drug target identification
  • pharmacokinetic prediction
  • toxicity prediction

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Kant, S., Deepika, & Roy, S. (2025). Artificial intelligence in drug discovery and development: transforming challenges into opportunities. Discover Pharmaceutical Sciences, 1(1). https://doi.org/10.1007/s44395-025-00007-3

How many times has this paper been cited?

89 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Discover Pharmaceutical Sciences.

Who wrote this paper?

Shashi Kant, Deepika, Saheli Roy.

What is the DOI of this paper?

10.1007/s44395-025-00007-3. The permanent link is https://doi.org/10.1007/s44395-025-00007-3.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.